PharmaShots Weekly Snapshot (Jun 01-05, 2020)
Published: Jun 04, 2020 | Tags: Novartis, Reports, Enerzair Breezhaler, QVM149, P-IIIb, ARGON Study, Treat, Uncontrolled Asthma
2. Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
Published: Jun 04, 2020 | Tags: Melinta Therapeutics, Acquire, Tetraphase Pharmaceuticals
Published: Jun 04, 2020 | Tags: AstraZeneca, Collaborates, CEPI, GAVI, SII, Equitable Access,Oxford Universitys COVID-19 Vaccine
Published: Jun 04, 2020 | Tags: Roche, Elecsys IL-6 Test, Receives, US, FDA, EUA, Identify Patients, High Risk, Severe Inflammatory Response, COVID-19
5. AstraZeneca Signs Exclusive Worldwide License Agreement with Accent for RMP-Targeting Therapies
Published: Jun 03, 2020 | Tags: Accent, Signs, Exclusive, Worldwide, License Agreement, AstraZeneca, RMP-Targeting Therapies
6. Mylan and Lupin Receive ECs MAA for Nepexto (biosimilar, etanercept)
Published: Jun 04, 2020 | Tags: Mylan, Lupin, Receive, EC, MAA ,Nepexto, biosimilar, etanercept
7. Fresenius Kabi Reports the US FDAs Acceptance of BLA for its MSB11455 (biosimilar, pegfilgrastim)
Published: Jun 04, 2020 | Tags: Fresenius Kabi, Reports, US, FDA, Acceptance, BLA, MSB11455, biosimilar, pegfilgrastim
8. Inovio to Initiate P-I/II Study of INO-4800 Against COVID-19 in South Korea
Published: Jun 03, 2020 | Tags: Inovio, Initiate, P-I/II, Study, INO-4800, Against, COVID-19, South Korea
Published: Jun 03, 2020 | Tags: Y-mAbs, Reports, US, FDA, Acceptance, Priority Review, Danyelza, naxitamab, BLA, Treat, Neuroblastoma
10. Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for COVID-19
Published: Jun 02, 2020 | Tags: Intravacc, EpiVax, Collaborate, Develop, Emerging Vaccine, COVID-19
Published: Jun 03, 2020 | Tags: Eli Lilly, Present Data, Taltz, ixekizumab, Patients, Psoriatic Arthritis, EULAR 2020, #EULAR
Published: Jun 03, 2020 | Tags: Lilly, Reveals, New Data, Olumiant, baricitinib, Treat, Rheumatoid Arthritis, Systemic Lupus Erythematosus, #EULAR
13. Celltrion Anticipates the Launch of Insulin Pen Biosimilar by 2025
Published: Jun 03, 2020 | Tags: Celltrion, Anticipates, Launch, Insulin Pen, Biosimilar, 2025
Published: Jun 03, 2020 | Tags: Personalis, Collaborates, Sarepta Therapeutics, Immune Response, Precision Genetic Therapeutics
Published: Jun 03, 2020 | Tags: US, FDA, Extends, Review, sBLA, Ofatumumab, OMB157, Patients, Relapsing Multiple Sclerosis
16. Henlius and Accord Receive CHMPs Positive Opinion for its HLX02 (biosimilar, trastuzumab)
Published: Jun 02, 2020 | Tags: Henlius, Accord, Receive, CHMP, Positive Opinion, HLX02, biosimilar, trastuzumab
17. Revance and Mylan to Advance Development Program for a Proposed Biosimilar to BOTOX
Published: Jun 02, 2020 | Tags: Revance, Mylan, Advance, Development Program, Proposed Biosimilar, BOTOX
Published: Jun 02, 2020 | Tags: Roche, Tecentriq, Avastin, Receive, US, FDA, Approval, Unresectable, Metastatic, Hepatocellular Carcinoma
Published: Jun 01, 2020 | Tags: Sanofi, Sarclisa, isatuximab, Receives, EC, Approval, Adults, Relapsed, Refractory, Multiple Myeloma
20. Regeneron and Intellia Expand Their 2016 Collaboration to Develop CRISPR/CAS9 Based Therapies
Published: Jun 02, 2020 | Tags: Regeneron, Intellia, Expand, 2016, Collaboration, Develop, CRISPR/CAS9 Based Therapies
Published: Jun 02, 2020 | Tags: Eli Lilly, Initiates, World, First, Clinical Study, Evaluate, Potential, COVID-19, Antibody, Treatment, Humans
Published: May 29, 2020 | Tags: AstraZeneca, Daiichi Sankyo, Enhertu, fam-trastuzumab deruxtecan-nxki, HER2-Positive, Metastatic Colorectal Cancer, HER2-Mutant, Non-Small Cell Lung Cancer, #ASCO20
Published: May 29, 2020 | Tags: AstraZeneca, Reports, Results, Tagrisso, osimertinib, P-III, ADAURA, Study, EGFR-Mutated Lung Cancer
Published: Jun 01, 2020 | Tags: Takeda, Present, Results, Iclusig, ponatinib, P-II, OPTIC Study, Chronic Myeloid Leukemia, Chronic Phase, ASCO, EHA, #ASCO20
Published: May 29, 2020 | Tags: Merck, Report, Result, Keytruda, (pembrolizumab), P-III, KEYNOTE-177, Patients, MSI-H Colorectal Cancer, #ASCO20
Published: May 26, 2020 | Tags: Seattle Genetics, Report, Updated Results, Tukysa (tucatinib), HER2CLIMB Study, HER2-Positive Breast Cancer, Stable, Active, Brain Metastases, #ASCO20
Published: May 29, 2020 | Tags: Merck KGaA, Pfizer, Demonstrates, Potential, Bavencio, Avelumab, Gestational Trophoblastic Tumors, ASCO20
28. AbbVie Signs a Worldwide License Agreement with Jacobio to Advance SHP2 Inhibitors
Published: May 29, 2020 | Tags: AbbVie, Signs, Worldwide, License Agreement, Jacobio, Advance, SHP2 Inhibitors
29. Amgen Reports Clinical Data of AMG 510 in CodeBreaK 100 Study for Multiple Solid Tumors #ASCO20
Published: May 29, 2020 | Tags: Amgen, Reports, Clinical Data, AMG 510, CodeBreaK 100, Study, Multiple Solid Tumors, #ASCO20
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com